SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $1,722,216,880 |
| Positions | 25 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| EDGEWISE THERAPEUTICS INC | EWTX | COM | $217,370,500 | 5,350,000 |
| ASML HOLDING N V | ASML | N Y REGISTRY SHS | $188,889,370 | 94,946 |
| HEMAB THERAPEUTICS HLDGS INC | COAG | COM SHS | $153,551,602 | 4,180,550 |
| BROOKFIELD CORP | BN | CL A LTD VT SH | $149,534,399 | 3,496,245 |
| MAPLIGHT THERAPEUTICS INC | MPLT | COM | $132,128,532 | 3,686,622 |
| MIRUM PHARMACEUTICALS INC | MIRM | COM | $131,703,750 | 1,125,000 |
| AVALYN PHARMACEUTICALS INC | AVLN | COM SHS | $127,837,874 | 3,883,289 |
| SALESFORCE INC | CRM | COM | $61,596,675 | 393,187 |
| ARRIVENT BIOPHARMA INC | AVBP | COM | $52,110,000 | 1,500,000 |
| ENLIVEN THERAPEUTICS INC | ELVN | COM | $50,750,000 | 1,000,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.